🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was designed to evaluate the safety, tolerability, pharmacodynam...
Status
Active Not Recruiting
Location
Clínica Imbanaco S.A.S
Start Date
2015-10-29
Trial ID
NCT02562235
Treatments Being Tested
Riociguat could improve the exercise capacity and residual symptoms in pati...
Status
Unknown
Location
National Hospital Org anization Okayama Medical Center
Start Date
2020-10-16
Trial ID
NCT04600492
Treatments Being Tested
To investigate the pharmacokinetic drug-drug interaction potential of fixed...
Status
Completed
Location
Multiple Locations
Start Date
2016-02-23
Trial ID
NCT02556268
To investigate relative bioavailability of crushed tablets suspended in app...
Status
Completed
Location
Multiple Locations
Start Date
2014-06
Trial ID
NCT02159313
Treatments Being Tested
This is an open-label, single-armed, prospective single-centre clinical stu...
Status
Terminated
Location
Centre for Pulmonary Hypertension at the Thoraxklinik Heidelberg, Heidelberg University Hospital
Start Date
2022-04-13
Trial ID
NCT04954742
Treatments Being Tested
The aim of the study is to assess the efficacy and safety of different dose...
Status
Completed
Location
Multiple Locations
Start Date
2009-02-23
Trial ID
NCT00855465
Treatments Being Tested
Physicians might be concerned that Adempas may have a metabolic interaction...
Status
Completed
Location
Multiple Locations
Start Date
2014-06
Trial ID
NCT02159326
Treatments Being Tested
Pulmonary Arterial Hypertension (PAH) is a severe progressive disease with ...
Status
Completed
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01179334
Treatments Being Tested
Single dose oral bioequivalence study of Riociguat 2.5 mg film coated table...
Status
Completed
Location
Cliantha Research Limited
Start Date
2023-03-07
Trial ID
NCT06180096
Treatments Being Tested
This study is to demonstrate the safety, tolerability, pharmakokinetic and ...
Status
Completed
Location
Multiple Locations
Start Date
2008-08
Trial ID
NCT00640315
Treatments Being Tested